Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at alternating eribulin and hormone therapy for advanced breast cancer

Overview

Cancer types:

Breast cancer

Status:

Closed

Phase:

Phase 2

Details

This trial is for women whose disease has spread into surrounding tissue or to another part of the body. They should also have oestrogen receptor positive breast cancer.

Recruitment start: 28 October 2015

Recruitment end: 28 February 2018

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Laura Kenny

Supported by

Action Against Cancer

Eisai

Experimental Cancer Medicine Centre (ECMC)

Imperial College of Science Technology and Medicine

Last reviewed: 28 Feb 2018

CRUK internal database number: 14050

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.